[
    [
        {
            "time": "2019-年报及2020-一季度报期间",
            "original_text": "金域医学（603882）：业绩稳健增长，规模效应凸显【2019年报及2020年一季报点评|西南医药朱国广/杜向阳团队】",
            "features": {
                "keywords": [
                    "金域医学",
                    "业绩稳健增长",
                    "规模效应",
                    "2019年报",
                    "2020一季报"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "金域医学（603882）：业绩稳健增长，规模效应凸显【2019年报及2020年一季报点评|西南医药朱国广/杜向阳团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "新冠核酸检测相关时期",
            "original_text": "新冠核酸检测公司业绩冰火两重天 行业空间还有多大？",
            "features": {
                "keywords": [
                    "新冠核酸检测",
                    "公司业绩",
                    "冰火两重天",
                    "行业空间"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "新冠核酸检测公司业绩冰火两重天 行业空间还有多大？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "A股早报2020年4月30日星期四",
            "features": {
                "keywords": [
                    "A股早报",
                    "2020-04-30"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股早报2020年4月30日星期四",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]